Accuracy, readability, and understandability of large language models for prostate cancer information to the public
Top Cited Papers
Open Access
- 14 May 2024
- journal article
- research article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 28 (2) , 394-399
Abstract
Background: Generative Pretrained Model (GPT) chatbots have gained popularity since the public release of ChatGPT. Studies have evaluated the ability of different GPT models to provide information about medical conditions. To date, no study has assessed the quality of ChatGPT outputs to prostate cancer related questions from both the physician and public perspective while optimizing outputs for patient consumption. Methods: Nine prostate cancer-related questions, identified through Google Trends (Global), were categorized into diagnosis, treatment, and postoperative follow-up. These questions were processed using ChatGPT 3.5, and the responses were recorded. Subsequently, these responses were re-inputted into ChatGPT to create simplified summaries understandable at a sixth-grade level. Readability of both the original ChatGPT responses and the layperson summaries was evaluated using validated readability tools. A survey was conducted among urology providers (urologists and urologists in training) to rate the original ChatGPT responses for accuracy, completeness, and clarity using a 5-point Likert scale. Furthermore, two independent reviewers evaluated the layperson summaries on correctness trifecta: accuracy, completeness, and decision-making sufficiency. Public assessment of the simplified summaries’ clarity and understandability was carried out through Amazon Mechanical Turk (MTurk). Participants rated the clarity and demonstrated their understanding through a multiple-choice question. Results: GPT-generated output was deemed correct by 71.7% to 94.3% of raters (36 urologists, 17 urology residents) across 9 scenarios. GPT-generated simplified layperson summaries of this output was rated as accurate in 8 of 9 (88.9%) scenarios and sufficient for a patient to make a decision in 8 of 9 (88.9%) scenarios. Mean readability of layperson summaries was higher than original GPT outputs ([original ChatGPT v. simplified ChatGPT, mean (SD), p-value] Flesch Reading Ease: 36.5(9.1) v. 70.2(11.2), p < 0.0001; Flesch Grade Level: 12.8(1.2) v. 7.4(1.7), p < 0.0001; Coleman Liau: 13.7(2.1) v. 8.6(2.4), 0.0002; Smog index: 11.8(1.2) v. 6.7(1.8), p < 0.0001). MTurk workers (n = 514) rated the layperson summaries as correct (89.5–95.7%) and correctly understood the content (63.0–87.4%). Conclusion: GPT shows promise for correct patient education for prostate cancer-related contents, but the technology is not designed for delivering patients information. Prompting the model to respond with accuracy, completeness, clarity and readability may enhance its utility when used for GPT-powered medical chatbots.Keywords
This publication has 44 references indexed in Scilit:
- Evaluating the Performance of Different Large Language Models on Health Consultation and Patient Education in UrolithiasisJournal of Medical Systems, 2023
- Assessment of Artificial Intelligence Chatbot Responses to Top Searched Queries About CancerJAMA Oncology, 2023
- How Well Do Artificial Intelligence Chatbots Respond to the Top Search Queries About Urological Malignancies?European Urology, 2023
- The utility of the ChatGPT artificial intelligence tool for patient education and enquiry in robotic radical prostatectomyInternational Urology and Nephrology, 2023
- Diagnostic and Management Applications of ChatGPT in Structured Otolaryngology Clinical ScenariosOTO Open, 2023
- Clinical Patient Summaries Not Fit for Purpose: A Study in UrologyEuropean Urology Focus, 2023
- Is ChatGPT an Evidence-based Doctor?European Urology, 2023
- Patient decision-making in symptomatic gallbladder diseaseSurgical Endoscopy, 2022
- Asking “Dr. Google” for a Second Opinion: The Devil Is in the DetailsEuropean Urology Focus, 2021
- Consulting “Dr. Google” for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend AnalysisEuropean Urology Oncology, 2019